Zobrazeno 1 - 10 of 10 pro vyhledávání: '"J M Schattenberg"'
1
Akademický článek
Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
Autor: L Kaps, C J Ahlbrand, R Gadban, M Nagel, C Labenz, P Klimpke, S Holtz, S Boedecker, M Michel, W M Kremer, M Hilscher, P R Galle, D Kraus, J M Schattenberg, J Weinmann-Menke
Publikováno v: PLoS ONE, Vol 16, Iss 4, p e0249342 (2021)
BackgroundADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous tr
Externí odkaz: https://doaj.org/article/576f35213fdb4a41b82bb96c85c0a16b
Zobrazit plný text záznamu
2
[Liver injury induced by immune checkpoint inhibitor-therapy : Example of an immune-mediated drug side effect]
Autor: B K, Straub, D A, Ridder, A, Schad, C, Loquai, J M, Schattenberg
Publikováno v: Der Pathologe. 39(6)
Drug-induced liver injury is increasing, especially in elderly patients with polymedication and multimorbidity.Clinicopathologic correlation of immune-mediated liver injury, specifically liver injury following therapy with immune checkpoint inhibitor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::875152b0d7d4659b770c856b4b88b764
https://pubmed.ncbi.nlm.nih.gov/30310977
Zobrazit plný text záznamu
4
[Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure]
Autor: F, Foerster, M A, Wörns, P R, Galle, J M, Schattenberg
Publikováno v: Zeitschrift fur Gastroenterologie. 53(12)
Direct acting antivirals (DAAs) have increased cure rates for chronic hepatitis C infection up to nearly 100 %. At the same time treatment costs have risen significantly. Treating all HCV infected patients in Germany with DAAs would generate medicati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5ec96f7e4de0b25c7459cc215c30c2f2
https://pubmed.ncbi.nlm.nih.gov/26757364
Zobrazit plný text záznamu
6
[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]
Autor: J, Weiss, M, Rau, H, Bantel, H, Bock, M, Demir, J, Kluwe, M, Krawczyk, A, Pathil-Warth, J M, Schattenberg, F, Tacke, E, Roeb, A, Geier, A, Zipprich
Publikováno v: Zeitschrift fur Gastroenterologie. 53(6)
Non-alcoholic fatty liver disease (NAFLD) currently is one oft the most common reasons for chronic liver injury in the western world. In the European and American population the prevalence is up to 30 %. The medical supply of German patients with NAF
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8c4f9653875cfb77c3516cf70bf2262b
https://pubmed.ncbi.nlm.nih.gov/26079073
Zobrazit plný text záznamu
7
[Etiology and complications of liver cirrhosis: data from a German centre]
Autor: V, Sivanathan, J M, Kittner, M F, Sprinzl, A, Weinmann, S, Koch, J, Wiltink, M, Nguyen-Tat, J U, Marquardt, M A, Wörns, T, Zimmermann, H, Lang, P R, Galle, J M, Schattenberg
Publikováno v: Deutsche medizinische Wochenschrift (1946). 139(36)
Liver cirrhosis develops as a terminal complication of chronic liver disease. The clinical course is determined by the underlying etiology and the accompanying risk factors, which are influenced by the geographic and cultural background.A total of 23
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::61d811f6e46fede3155f44405885c32c
https://pubmed.ncbi.nlm.nih.gov/25157862
Zobrazit plný text záznamu
8
[Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature]
Autor: S, Rösner, A, Schad, J, Kittner, F, Rahman, M A, Wörns, M, Schuchmann, P R, Galle, J M, Schattenberg
Publikováno v: Zeitschrift fur Gastroenterologie. 52(1)
Therapeutic agents to inhibit tumour necrosis factor alpha (TNF-α) have dramatically improved the treatment options for patients with autoimmune diseases. Common side effects include an increased susceptibility towards infection. Hepatic side effect
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::764395132817b064ec67720e16ec49d8
https://pubmed.ncbi.nlm.nih.gov/24420801
Zobrazit plný text záznamu
9
Leptomeningeal familial amyloidosis
Autor: J. Gawehn, Peter P. Urban, J. M. Schattenberg, Klaus Altland, S. Hägele, M. Wunsch, C. Hertkorn
Publikováno v: Journal of Neurology. 253:1238-1240
Sirs: We report on a 31-year old woman with a known history of familial amyloidosis with the transthyretin (TTR) variant Leu12Pro. The pedigree can be traced back to the year 1780. For three years the patient had suffered from a primary partial secon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::539b961d091c1883606216808f5c7dac
https://doi.org/10.1007/s00415-006-0169-0
Zobrazit plný text záznamu
10
[Acute liver failure--medical viewpoints]
Autor: J M, Schattenberg, P R, Galle, M, Schuchmann
Publikováno v: Praxis. 95(48)
Acute liver failure is a rare disease that can cause death in the majority of untreated cases. Sudden loss of liver function in the absence of a preexisting liver disease is considered the true form and has to be distinguished from impaired function
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3d6d6b21ad0aa49c2eb3388301e55dae
https://pubmed.ncbi.nlm.nih.gov/17176926
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje